Expert National Meeting BRINGING IMMUNOSCIENCE TO THE CLINIC 10 January 2024

Materials from past ISA meetings are only available for your information, it reflects the state of sciences at the time of the meeting.

Presentations from past ISA meetings are available for your information; it reflects the state of sciences at the time of the presentation

In the context of 5 years of ImmunoScience Academy, the national meeting entitled “Bringing ImmunoScience to the Clinic” covered immunotherapy in earlier stages of malignancies, novel concepts in oncology such as gut microbiome and bispecifics, and relevant topics for the day-to-day clinical practice.

Intro Plenary Expert Panel session Intro Plenary Expert Panel session

MOVING CANCER IMMUNOTHERAPY
TOWARDS EARLIER STAGES OF DISEASE

Theory and practice

Prof Pierre Coulie, President of the ImmunoScience Academy —
de Duve Institute — UCL
Prof Ahmad Awada — Jules Bordet Institute — HUB

WHAT’S NEW IN TREATING IMMUNOTHERAPY-TOXICITY IN 2024?

Dr Stefan Rauh — CHEM Luxemburg
Prof Sandrine Aspeslagh— UZ Brussel

WHEN TO STOP OR RESUME IMMUNOTHERAPY?
DATA FORM MELANOMA, LUNG AND GI CANCER

Prof Eric Van Cutsem — UZ Leuven
Prof Johan Vansteenkiste — UZ Leuven
Prof Bart Neyns — UZ Brussel

IMAGING FOR IMMUNOTHERAPY MANAGEMENT, WHAT SHOULD YOU KNOW FOR CLINICAL PRACTICE?

Dr François Cousin — CHU Liège
Prof Vincent Vandecaveye — UZ Leuven
Moderator: Prof Guy Jerusalem — CHU Liège

RAPID EMERGENCE OF THE GUT MICROBIOME IN CANCER IMMUNOTHERAPY

Dr Bertrand Routy — Montréal Canada
Moderator: Dr Stefan Rauh — CHEM Luxemburg

NOVELTIES IN BISPECIFIC AGENTS FOR HEMATOLOGY AND SOLID TUMORS

Prof Tessa Kerre — UZ Gent
Moderator: Dr Stefan Rauh — CHEM Luxemburg

DRUG INTERFERENCE DURING IMMUNOTHERAPY

Dr Bertrand Routy — Montréal Canada
Dr Maxime Ilzkovitz — Jules Bordet Institute – HUB
Moderator: Prof Ahmad Awada — Jules Bordet Institute – HUB

PATIENT EDUCATION: EXAMPLES FROM ACADEMIC CENTERS IN BELGIUM

Prof Tessa Kerre — UZ Gent
Dr Sylvie Streel — CHU Liège
Mrs Marie Vandevelde — UZ Leuven
Moderator: Prof Johan Vansteenkiste — UZ Leuven

CAR T VS BISPECIFICS: HOW TO MANAGE TOXICITY AND SEQUENCING

Prof Jo Caers — CHU Liège
Prof Peter Vandenberghe — UZ Leuven
Moderator: Prof Rik Schots — UZ Brussel